HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.

AbstractOBJECTIVE:
To evaluate the efficacy and safety of home administration of buccal misoprostol after mifepristone for medical abortion up to 70 days' gestation in a general practice in Curaçao, where induced abortion is severely restricted by law.
METHODS:
In a prospective study 330 women received 200 mg mifepristone and were instructed to take four tablets (800 μg) of misoprostol via the buccal route 24-36 h later, at home. One week later, follow-up took place.
RESULTS:
The outcome could be evaluated in 307 of the 330 women. The efficacy of the mifepristone-buccal misoprostol procedure was 97.7% (300/307). In seven women vacuum aspirations for continuing pregnancy or incomplete abortion following treatment were required. Success rates at 64-70 days' gestation were the same as for gestations of less than 64 days duration. The main adverse effects were nausea and diarrhoea.
CONCLUSION:
Home administration of buccal misoprostol 24-36 h after mifepristone is a safe and effective method of medical abortion up to 70 days. It could be applied in a general practice in Curaçao, where induced abortion is legally restricted.
AuthorsAdriana A Boersma, Betty Meyboom-de Jong, Gunilla Kleiverda
JournalThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (Eur J Contracept Reprod Health Care) Vol. 16 Issue 2 Pg. 61-6 (Apr 2011) ISSN: 1473-0782 [Electronic] England
PMID21303309 (Publication Type: Journal Article)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Misoprostol
  • Mifepristone
Topics
  • Abortifacient Agents, Nonsteroidal (administration & dosage)
  • Abortifacient Agents, Steroidal (administration & dosage)
  • Abortion, Induced (methods)
  • Administration, Buccal
  • Adult
  • Ambulatory Care Facilities
  • Amenorrhea (chemically induced)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Mifepristone (administration & dosage)
  • Misoprostol (administration & dosage)
  • Netherlands Antilles
  • Pregnancy
  • Prospective Studies
  • Self Administration (methods)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: